Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Valerin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Medicine|November 4, 2025
Adequate Catchment Area Representation in Cancer Clinical Trials at NCI Designated Cancer Centers: The University of California Irvine ExperienceFrank Lee, Aditya Mahadevan, Armon Azizi, et al.
Clinical Advances in Hematology & Oncology : H&O|July 29, 2025
First-line use of antiangiogenic agents in unresectable hepatocellular carcinoma: a double-edged sword?Aditya Mahadevan, Armon Azizi, Nadine Abi-Jaoudeh, et al.
Medical Oncology (Northwood, London, England)|May 22, 2022
A phase 1b multicenter study of TAS-102 in combination with irinotecan in patients with advanced recurrent or unresectable gastric and gastroesophageal adenocarcinoma after at least one line of treatment with a fluoropyrimidine and platinum-containing regimenFarshid Dayyani, Kit Tam, Edward J Kim, et al.
Clinical Colorectal Cancer|December 16, 2023
A Phase 1 Study of Cabozantinib and Trifluridine/Tipiracil in Metastatic Colorectal AdenocarcinomaFarshid Dayyani, Jasmine Balangue, Jennifer Valerin, et al.
Cells|February 12, 2025
Promising Cellular Immunotherapy for Colorectal Cancer Using Classical Dendritic Cells and Natural Killer T CellsMahmoud Singer, Jennifer Valerin, Zhuoli Zhang, et al.
Cancers|January 11, 2025
Modulation of Tumor-Associated Macrophages to Overcome Immune Suppression in the Hepatocellular Carcinoma MicroenvironmentMahmoud Singer, Zhuoli Zhang, Farshid Dayyani, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 9, 2026
Outcomes of Irreversible Electroporation for Treatment of Refractory Locally Advanced Pancreatic CancerRicardo Azevedo, David Imagawa, Marianne Rara, et al.
Cancer Medicine|December 5, 2025
Predicting Benefit of Neoadjuvant Chemotherapy and Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervised Machine Learning ApproachGarrett K Harada, Jino Park, Nicholas Peterson, et al.
Journal of Adolescent and Young Adult Oncology|January 25, 2023
Unmet Needs, Barriers, and Facilitators for Conducting Adolescent and Young Adult Cancer Survivorship Research in Southern California: A Delphi SurveyAlexandre Chan, Kayleen Ports, Ding Quan Ng, et al.
Research Square|October 4, 2023
Increased AID Results in Mutations at the CRLF2 Locus Implicated in Latin American ALL Health DisparitiesNicholas Pannunzio, Valeria Rangel, Jason Sterrenberg, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Medicine|November 4, 2025
Adequate Catchment Area Representation in Cancer Clinical Trials at NCI Designated Cancer Centers: The University of California Irvine ExperienceFrank Lee, Aditya Mahadevan, Armon Azizi, et al.
Clinical Advances in Hematology & Oncology : H&O|July 29, 2025
First-line use of antiangiogenic agents in unresectable hepatocellular carcinoma: a double-edged sword?Aditya Mahadevan, Armon Azizi, Nadine Abi-Jaoudeh, et al.
Medical Oncology (Northwood, London, England)|May 22, 2022
A phase 1b multicenter study of TAS-102 in combination with irinotecan in patients with advanced recurrent or unresectable gastric and gastroesophageal adenocarcinoma after at least one line of treatment with a fluoropyrimidine and platinum-containing regimenFarshid Dayyani, Kit Tam, Edward J Kim, et al.
Clinical Colorectal Cancer|December 16, 2023
A Phase 1 Study of Cabozantinib and Trifluridine/Tipiracil in Metastatic Colorectal AdenocarcinomaFarshid Dayyani, Jasmine Balangue, Jennifer Valerin, et al.
Cells|February 12, 2025
Promising Cellular Immunotherapy for Colorectal Cancer Using Classical Dendritic Cells and Natural Killer T CellsMahmoud Singer, Jennifer Valerin, Zhuoli Zhang, et al.
Cancers|January 11, 2025
Modulation of Tumor-Associated Macrophages to Overcome Immune Suppression in the Hepatocellular Carcinoma MicroenvironmentMahmoud Singer, Zhuoli Zhang, Farshid Dayyani, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 9, 2026
Outcomes of Irreversible Electroporation for Treatment of Refractory Locally Advanced Pancreatic CancerRicardo Azevedo, David Imagawa, Marianne Rara, et al.
Cancer Medicine|December 5, 2025
Predicting Benefit of Neoadjuvant Chemotherapy and Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervised Machine Learning ApproachGarrett K Harada, Jino Park, Nicholas Peterson, et al.
Journal of Adolescent and Young Adult Oncology|January 25, 2023
Unmet Needs, Barriers, and Facilitators for Conducting Adolescent and Young Adult Cancer Survivorship Research in Southern California: A Delphi SurveyAlexandre Chan, Kayleen Ports, Ding Quan Ng, et al.
Research Square|October 4, 2023
Increased AID Results in Mutations at the CRLF2 Locus Implicated in Latin American ALL Health DisparitiesNicholas Pannunzio, Valeria Rangel, Jason Sterrenberg, et al.
Pageof 1